Pharm Tech Minutes 2019.03.22

From IHE Wiki
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Agenda

Welcome

  • Participants
  • Jürgen Brandstätter
  • Stephane Spahni
  • Leonidas Tzimis
  • Review and Approve Agenda
  • Approved
  • Approved


Schedule / F2F meetings

  • Preparation of April F2F ==
  • Meeting on Wednesday 10th / Thusday 11th April 2019 Rennes
  • Organizationsl status
  • Stephane: All is arranged (Room, Catering, Badges, etc.)
  • Preparing agenda
  • Action item: Assemble a draft agenda (Jürgen)
  • Schedule, Roadmap, Strategic goals
  • New and present work items
  • Finalize Supply chain whitepaper
  • ADER
  • FHIR: Gemini, MMA, UPB, Future?
  • Medication Information Sharing / Unicom
  • Setting profiles to "Final text"
  • What to do about F2F June/ joint meeting ITI, PCC, QRPH in July
  • Status
  • No information on signed MoU with Treviso yet
  • Action item: Follow-up with Sarah Bell (Jürgen)


Collaboration on e-Precription (WHO CEN collaboration Digital Health)

  • Status
  • There was a meeting of IPS at 19th March Bruxelles
  • No information available


Webinar

  • Progress webinar activities
  • Status
  • No status available, because Esther not present
  • Should be worked on in F2F meeting Rennes
  • Action item: Ask Esther to prepare status report / preparation to do some work in Rennes (Jürgen)


New work item

  • Unicom project (Stephane)
  • EU Horizon 2020 project: "Upscaling the global identification of medicines"
  • Follow up of "OpenMedicine" project
  • Quite large: 90M€ over 3-4 years
  • Administative coordinator: Empirica
  • IHE Europe was asked to participate to this EU project, operationally lead by EU Affairs
  • Not yes approved, currently in proposal phase
  • Needs involvement of IHE Pharmacy experts
  • In form of subcontracting to IHE Europe / EU Affairs
  • Question to IHE Pharmacy about a feasible fee
  • Discussion
  • Formally, IHE Pharmacy as committee cannot participate in such projects
  • Members of the group may participate on individual basis
  • Question on fee can not be answered, depends on individual
  • What can we offer to EU Affairs, once the project is approved:
  • Option 1: Circulating this "opportunity for engagement" to all IHE Pharmacy members, to offer themselves as consultant to EU Affairs
  • Option 2: Provide the list of IHE Pharmacy members to EU Affairs, EU Affairs chooses and picks individuals to contact or issues "opportunity for engagement" themselves
  • Decision: IHE Pharmacy contact to EU Affairs is Stephane Spahni
  • Action item: Inform EU Affairs about discussion and the options we can offer (Stephane)


Present Work items

  • Adverse Drug Event Reporting (ADER) (Michael)
  • Status
  • No status because Michael is not present
  • Stephane: Received several inquiries how to document adverse events, would like to cover this topic at F2F
  • Action item: Ask Michael to prepare status report / preparation to do some work in Rennes (Jürgen)
  • Supply Flow Profile (Esther)
  • Status
  • No status because Esther and Jose are not present
  • FHIR Versions of the remaining existing Community Profiles (CMPD, PRE, DIS, PADV, PML, MTP) (Stephane)
  • Status
  • No progress
  • Discussion
  • This project is too big to do it without a real-world project in the back for funding
  • Potential stakeholdes are approached in Switzerland in 2019 via a report by Stephane
  • Pre-Prescription (Stephane)
  • Status
  • Stephane did not receive any answer on request for feedback on the CP
  • Action item: Resend the request (Stephane)


Any other business

  • Setting profiles to "Final text"
  • Decision: Topic will be discussed at F2F in Rennes


Pharmacy Technical Committee